Enzyme therapy for Fabry patients in jeopardy.
Silversides
Ann
A
D002170:Canada; D017327:Clinical Trials, Phase IV as Topic / Q000191:economics*; D000795:Fabry Disease / Q000191:economics / Q000628:therapy*; D006801:Humans; D007527:Isoenzymes / Q000191:economics / Q000627:therapeutic use; D009313:National Health Programs / Q000191:economics*; D012109:Research Support as Topic; D000519:alpha-Galactosidase / Q000191:economics / Q000627:therapeutic use
D007527:Isoenzymes; D000519:alpha-Galactosidase; C459420:agalsidase beta